MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies

IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment

Seer and Thermo Fisher Scientific Announce Strategic Collaboration to Advance Proteomics with Integrated Platform Solution

SystImmune Secures FDA Clearance for IND Application of Novel ADC Therapy BL-M17D1 for Advanced Solid Tumors

Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma

Home
/
update
/
details

Mahajan Imaging & Labs Launches AI-Enhanced Advanced Cardiac Screening and Low-Dose Dual Energy Spectral CT Scanner for Comprehensive Imaging

NextEdge Admin

29 Jul 2024

2 min 17 sec

Mahajan Imaging & Labs, a leader in diagnostic services, has introduced a state-of-the-art Dual Energy Spectral CT scanner at their Gurugram centre. This advanced scanner ensures precise diagnoses across a range of medical conditions with a rotation speed of just 0.3 seconds, allowing quick scans without compromising image quality. A key benefit is the ultra-low-dose radiation, which is particularly advantageous for preventive cardiac scans and pediatric imaging. The AI-enabled software enhances early disease detection, especially in cardiac screening, and reduces radiation exposure for cardiac patients by up to 85%.

Dr. Harsh Mahajan, founder and chief radiologist, stated, "Our new dual-energy spectral CT scanner revolutionizes CT scanning by reducing scan times and radiation doses. This technology helps doctors identify heart diseases early and accurately." Dr. Shelly Mahajan, lab director and clinical lead, added, "This scanner is a step towards integrated diagnostics, offering advanced oncology tracking and CT-guided procedures for comprehensive diagnosis."

Mahajan Imaging & Labs operates high-end diagnostic centres across India, combining radiology, PET CT, genomics, pathology, and AI. They have pioneered technologies like Silent MRI, functional MRI, dual energy spectral CT, and 4D ultrasound. Their network includes 10 centres and 2 labs, with locations in Delhi NCR and prestigious hospitals like Sir Ganga Ram Hospital and Fortis Hospitals. Beyond clinical diagnostics, Mahajan Imaging & Labs is involved in advanced research with institutions such as MIT, Max Planck Institute, and AIIMS.